Gdx Zeiss Glaucoma Tester with new software, US $4,495.00 – Picture 0

Gdx Zeiss Glaucoma Tester with new software, US $4,495.00 – Picture 1

Gdx Zeiss Glaucoma Tester With New Software

US $4,495.00

Tampa, Florida, United States
Jan 30th

Open on mobile:
QR code

This is a fully functional GDX with updated software. It has been fully tested and calibrated by a factory trained technician. Early diagnostic program for glaucomaGlaucoma is a disease that causes thinning of the nerve fiber layer in the retina and over time results in a gradual loss of vision which could lead to blindness if left untreated. Glaucoma is often called the "thief of sight" because it is painless and symptoms appear slowly. In fact up to 50% of those with the disease remain unaware that they have it.the revolutionary Zeiss GDx testThe Zeiss GDx Nerve Fiber Analyzer test utilizes a revolutionary technology that can help detect early glaucoma before any vision loss has occurred. As a result, we will have more time to treat the disease and protect the vision.When the GDx scans your eyes it is measuring the thickness of the nerve fibre layer in the back of the eye by using an invisible, safe, low powered laser. The measurements of the nerve fibre layer are mapped by the software and compared to a database of normal values. The Optometrist interprets the examination findings in the clinical context of the patient as well as applying their observational skills of the optic nerve in their diagnosis. An abnormally thin nerve fibre layer may indicate that glaucoma is present.Who should be tested for glaucoma?Glaucoma can affect people of all ages and races however those at greatest risk are:People over the age of 40Anyone with high eye pressureAnyone with a family history of glaucomaPeople of African or Caribbean originDiabeticsAnyone who is very short-sightedLong-term steroid usersWhat is the advantage of the GDx examination over the standard test for glaucoma?The GDx examination can assist in detecting nerve fibre layer loss before any loss of vision has occurred and, therefore, the patient can be treated more quickly. The results are initially compared to a database of normal patients but upon further visits it also provides a comprehensive history that enables us to analyse the results and detect if there is any loss of nerve fibre thickness which may be an indication of glaucoma. We are regularly requested by Ophthalmologists to carry out GDx tests in the management of their glaucoma patients.The GDx is used for diagnosis of early glaucoma; for follow up of glaucoma patients under treatment and in relatives of glaucoma patients to establish a baseline from which to work as these people have a five times greater risk of glaucoma.